secwatch.observer — SEC 8-K summary
======================================

Issuer:     AtriCure, Inc. (ATRC)
CIK:        0001323885
Form:       8-K
Filed at:   2023-05-02T23:59:59+00:00
Accession:  0001323885-23-000045
Event type: earnings
Sentiment:  positive
Materiality: 0.75
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

AtriCure Q1 revenue $93.5M (+25.4% YoY), net loss narrows to $6.5M, positive adj. EBITDA $1.9M
--------------------------------------------------------------------------------

- Revenue $93.5M (+25.4% YoY); US $78.2M (+25.6%), Intl $15.3M (+24.4%).
- Net loss $6.5M improved $8.7M YoY; diluted EPS loss $0.14 vs $0.33.
- Adjusted EBITDA positive $1.9M vs negative $4.2M in prior year.
- FY 2023 revenue guidance $385-392M (17-19% growth); adj. EBITDA ~$2M; adj. EPS loss $1.10-$1.15.
- Gross margin 74.5% flat YoY; operating loss $5.8M improved from $14.2M.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1323885/000132388523000045/0001323885-23-000045-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1323885/000132388523000045/atrc-20230502.htm
  HTML page:      https://secwatch.observer/filing/0001323885-23-000045

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer